Cytokinetics: 3Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Cytokinetics Inc. (CYTK) on Thursday reported a loss of $22 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 40 cents.
The biopharmaceutical company posted revenue of $10.6 million in the period.
Cytokinetics shares have declined 15 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.90, a fall of 47 percent in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK